Sanara MedTech, Inc. (SMTI)
|Net Income (ttm)||-5.57M|
|Trading Day||March 5|
|Day's Range||26.39 - 29.85|
|52-Week Range||26.39 - 53.85|
These companies made millions by developing equipment for life-saving care, and enriched shareholders too.
FORT WORTH, TX / ACCESSWIRE / December 23, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (NASDAQ:SMTI), a provider of wound and skin ca...
Sanara MedTech develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical Activated Collagen Adjuvant powder that helps in the natural wound healing process; Biako¯s Antimicrobial Skin & Wound Cleanser, a patented wound cleansing spray that disrupts extracellular polymeric substances to eradicate biofilm; and Biako¯s Antimicrobial Skin & Wound Irrigation Solution that works to irrigate and remove microbes from the... [Read more...]
Medical Care Facilities
|Stock Exchange |
|Ticker Symbol |
In 2019, Sanara MedTech's revenue was $11.77 million, an increase of 101.56% compared to the previous year's $5.84 million. Losses were -$2.81 million, 368.6% more than in 2018.